Cannabis Law Report

JULY 28, 2021

The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable Clinical Trials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.

Clinical Trials

Cannabis Law Report

MAY 19, 2022

“We look at the diagnosis, the medical history, if there’s a risk of addiction, what treatments have already been tried …. Before January, people could only access psychedelic-assisted psychotherapy through clinical trials or medical exemptions. In April, a clinic called Roots To Thrive, in Nanaimo, B.C.,

Therapy

Cannabis Law Report

JULY 9, 2021

The use of psychedelic substances to treat mental illness and physical disorders is known as “psychedelic therapy.” In a typical scenario, psychedelic substances would be used in conjunction with psychotherapy sessions to treat disorders for which other medicinal therapies have failed. Psychedelic therapy is not a fringe phenomenon.

Law

PrestoDoctor

SEPTEMBER 15, 2023

While there are a variety of treatments available, many individuals do not find relief with traditional medications or therapies. However, exploring alternative treatment options, such as CBD , alongside traditional therapies can offer individuals with OCD a potential avenue for relief and improved symptom management.

Research and Development

Cannabis Law Report

AUGUST 3, 2021

FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S. Applied DNA is also the manufacturer of the EUA-authorized Linea™ COVID-19 Assay Kit. Food and Drug Administration (U.S.

Clinical Trials

Cannabis Law Report

SEPTEMBER 2, 2021

FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Food and Drug Administration (U.S.

Clinical Trials

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. In MAPS’ 36th year, we’ll learn if our second Phase 3 study of MDMA-assisted therapy for PTSD was successful. At 36, MAPS is now older than I was when I started MAPS at age 32.

Clinical Trials

MMJ Recs

JULY 11, 2024

Each type of insomnia may require different treatment approaches, including behavioral therapy, medication, lifestyle changes, or addressing underlying medical or psychological issues. However, more robust clinical trials are needed to validate these findings and determine the optimal dosages and treatment regimens for each disorder.

Sleep

Cannabis Law Report

NOVEMBER 1, 2021

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation.

Research and Development

Cannabis Law Report

DECEMBER 9, 2021

MindMed is a clinical-stage psychedelic medicine biotech company that seeks to discover, develop and deploy psychedelic-inspired medicines and therapies to address addiction and mental illness. NEW YORK , Dec. 9, 2021 /PRNewswire/ — Mind Medicine (MindMed) Inc. ” About MindMed. Forward-Looking Statements.

Research and Development

Cannabis Law Report

NOVEMBER 9, 2021

As an institution dedicated to diagnosing and treating serious blood diseases and with the ability to pursue investigational medicines from development to manufacture and clinical trial for patients who have exhausted all approved treatment options, having a cost-effective and rapid production chain is integral to ÚHKT’s mission.

Clinical Trials

Cannabis Law Report

MARCH 2, 2020

Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. A few months later, the agency awarded BTD for Usona Institute ‘s psilocybin therapy for major depressive disorder. Then, something strange happened.

Medicine

Cannabis Law Report

NOVEMBER 23, 2021

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation.

Law

Freedom Leaf

JULY 20, 2017

A study published by the Journal of Addiction Research and Therapy on Feb. They reported that subjects’ cannabis use history was correlated with a “small, yet consistent increase in odds” for hypertension, obesity and other risk factors. MetS risk factors are linked to cardiovascular diseases like heart attacks and strokes.

Blood Pressure

Cannabis Law Report

JUNE 19, 2022

In the United States, there are two leading drug-assisted therapies in phase 3 clinical trials testing MDMA (ecstasy) as a treatment for post-traumatic stress disorder and psilocybin for depression. Davis and Slot predicted that as things stand, these therapies could be federally approved in three to five years. “If

Education

Cannabis Law Report

JUNE 7, 2021

Department of Agriculture (USDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final or conditional approval from the U.S. Food and Drug Administration (U.S.

Clinical Trials

Otherside Farms

APRIL 30, 2019

The History Behind Cannabis as Medicine. It was thanks to this discovery that we have once again found cannabis and hemp as forms of medicines as it has been used throughout history. After several trials with traditional forms of therapy and medication with no long-term effectiveness, researchers decided to give CBD oil a shot.

Oil

Cannabis Law Report

NOVEMBER 15, 2021

PCR-produced LinearDNA serves as a pure, fast, and flexible alternative to plasmid DNA (pDNA) in the manufacture of cell and gene therapies (CGTs) and nucleic acid vaccines. CRO orders typically provide a means to evaluate LinearDNA within a customer’s preclinical development program. News release. FDA website. January 15, 2019. 2021.08.006.

Research and Development

MMJ Recs

MAY 9, 2024

These professionals can provide valuable insights into whether medical cannabis is a suitable option based on the veteran’s medical history, current conditions, and treatment goals. The VA offers a variety of mental health services, including counseling, therapy, and medication management, to support veterans in their recovery journey.

Research and Development

CannaTech

MARCH 24, 2019

In particular, research and development for cannabis-based therapies targeting women’s health challenges is making headway. The female reproductive system has the highest concentration of endocannabinoid receptors after the human brain, making it particularly receptive to cannabis-based therapies.

Research and Development

MMJ Recs

JUNE 15, 2022

There are many treatments that can be utilized along with MMJ products to alleviate pain, such as medications, physical therapy, and massage. Their website is a fount of information that indicates high patient satisfaction (including testimonials and data on clinical trials). Downtown Pain Physicians of Brooklyn.

Patients

Cannabis Law Report

NOVEMBER 24, 2019

Future studies will explore psilocybin’s effectiveness as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa, and alcohol use in people with major depression. Participate in Our Studies.

Therapy

LifeCannMD

JANUARY 31, 2025

The Generational Reality of Huntington’s Disease Huntington’s disease weaves itself into family histories in ways that extend far beyond its clinical description as a neurodegenerative condition. “Every patient I see brings more than just their symptoms.”

Conditions

Cannabis Law Report

OCTOBER 12, 2021

FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Food and Drug Administration (U.S.

Programs

PrestoDoctor

OCTOBER 11, 2023

In recent years, there has been growing interest in exploring alternative therapies for individuals with ASD. The plan should include other therapies and interventions tailored to the specific needs of the individual. They can provide guidance based on the individual’s specific needs and medical history.

CBD

Cannabis Law Report

NOVEMBER 1, 2021

The Company filed patent applications protecting its discovery of cannabinoid-based therapies where the A3AR target is overexpressed including liver cancer. About Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.

Clinical Trials

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Training Curriculum Recommendations.

Law

MMJ Recs

JULY 19, 2024

Amidst the limitations of conventional therapies and medications, there’s a growing curiosity and acceptance of alternative treatments for anxiety relief. Clinical Research Findings: What Studies Say About Cannabis and Anxiety Numerous studies have explored cannabis’s efficacy in alleviating anxiety symptoms.

Strains

Cannabis Law Report

DECEMBER 21, 2019

ASD is a worldwide problem that needs to be kept in check, and although currently there is no cure to the problem so many breakthroughs have been recorded via a couple of therapy procedures amongst which is the use of CBD. The major points critics bring up regarding this subject include: Uncertainties of the long term effects of the therapy.

Research and Development

Cannabis Law Report

SEPTEMBER 20, 2021

Delic expects to open 15 additional clinics across the country over the coming 18 months, further expanding access to millions who can benefit from psychedelic treatment for a variety of mental health conditions. Established history of providing ketamine infusion services: The management team at KWC has been in ?business

Treatment

Cannabis Law Report

DECEMBER 21, 2021

This calendar year marks a synchronous period in Dalrada’s history when its impactful innovations and solutions of all its subsidiaries expanded market presence into the top three largest growing industries : clean energy, healthcare, and technology. In its history, IHG has graduated nearly 8,000 students.

Research and Development

Cannabis Law Report

NOVEMBER 24, 2021

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. It also has an extensive and diverse history of medicinal use. 2018 ; Frankhauser 2008 ). We want to improve their quality of life.” (AM,

Research and Development

Canna Law Blog

NOVEMBER 27, 2021

Also, according to the DEA, “the history of human experience probably goes back several hundred years since DMT usage is associated with a number of religious practices and rituals.” is expanding rapidly as numerous neuropharmaceutical companies look to be among the first-to-market potentially revolutionary therapies.

Therapy

The Cannigma

DECEMBER 12, 2022

History: Magic mushrooms have likely been consumed as long as humans have roamed the earth – or possibly longer, according to Terrance McKenna’s “Stoned Ape Theory,” which suggests human evolution and language development was expedited by these mushrooms. History: Bufo is a slang term for the poisonous secretions of certain toads.

History

Canna Law Blog

OCTOBER 8, 2020

Oregon Psychedelics: Petition to Legalize Psilocybin for Therapy Moves Forward. For one, research on the benefits of psilocybin therapy in treating depression is farther along than most people think; the results are quite promising ; and more clinical trials are underway, including at esteemed research institutions like Johns Hopkins.

Research and Development

Greencamp

AUGUST 16, 2018

Brief history of ALS. Even though these effects were observed on mice, all mammals have neurological and cellular similarities, and the team in charge of this study concluded that: “With respect to the treatment of ALS, from both a disease modifying and symptom management viewpoint, clinical trials with cannabis are the next logical step.

Strains

Green Relief

MAY 13, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. government-sponsored scientific research – and to extensive anecdotal accounts from medical marijuana patients – which highlight the potential of cannabinoid-based therapies for TBI.

THC